questionText: To ask the Secretary of State for Health and Social Care, what recent discussions she has had with (a) the Chief Executive of NHS England and (b) NICE on regulatory approval of (i) Lecanemab, (ii) Donanemab and (iii) other medicines that could be used to manage the progression of Alzheimer’s disease.
answerText: The Department is working closely together with the Medicines and Healthcare products Regulatory Agency, the National Institute for Health and Care Excellence, NHS England, the devolved administrations, and the Dementia Mission to plan for the implementat...
heading: Alzheimer's Disease: Drugs